Table 5.
Intraobserver agreement of the live exercise | Interobserver agreement of the live exercise | |||||||||||
Prevalence mean range (%) | Observed agreement mean, range (%) | Kappa mean range | PABAK mean range | Prevalence mean I round (%) |
Prevalence mean II round (%) |
Observed agreement mean, I round (%) | Observed agreement, mean, II round (%) | Kappa mean I round |
Kappa mean II round |
PABAK mean I round |
PABAK mean II round |
|
Synovial hypertrophy (0–1) | 17 (9–26) | 89 (70–97) | 0.64 (0.10–0.85) | 0.78 (0.40–0.94) | 17 | 18 | 85 | 85 | 0.46 | 0.51 | 0.70 | 0.70 |
Joint effusion (0–1) |
15 (7–25) | 91 (81–98) | 0.62 (0.10–0.94) | 0.81 (0.63–0.98) | 16 | 14 | 85 | 87 | 0.40 | 0.43 | 0.69 | 0.73 |
Cartilage damage (0–1) |
88 (46–100) | 89 (75–100) | 0.5 (−0.12 to 1) | 0.79 (0.5–1) | 88 | 89 | 81 | 82 | 0.11 | 0.08 | 0.61 | 0.65 |
Synovial hypertrophy score (0–3) | 12 (5–21) grade 1; 7 (1–12) grade 2; 1 (0–3) grade 3 | 85 (68–95) | 0.64 (0.13–0.80) | 0.78 (0.58–0.94) | 12 (grade 1) 6 (grade 2) 1 (grade 3) |
11 (grade 1) 7 (grade 2) 1 (grade 3) |
78 | 79 | 0.37 | 0.37 | 0.71 | 0.73 |
Power Doppler score (0–3) | 3 (1–12) grade 1; 1 (0–3) grade 2; 0 (0–0) grade 3 |
96 (89–99) | 0.41 (−0.01 to 0.79) | 0.95 (0.86–0.98) | 3 (grade 1) 1 (grade 2) 0 (grade 3) |
3 (grade 1) 1 (grade 2) 0 (grade 3) |
94 | 94 | 0.21 | 0.18 | 0.93 | 0.93 |
Osteophytes score (0–3) | 36 (17–66) grade 1; 10 (3–25) grade 2; 2 (0–8) grade 3 | 72 (59–90) | 0.46 (0.21–0.78) | 0.62 (0.45–0.86) | 36 (grade 1) 10 (grade 2) 2 (grade 3) |
36 (grade 1) 10 (grade 2) 2 (grade 3) |
53 | 52 | 0.19 | 0.21 | 0.36 | 0.36 |
MTP, metatarsophalangeal; PABAK, prevalence-adjusted bias-adjusted kappa.